Te Ahumairangi Investment Management Ltd Cuts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Te Ahumairangi Investment Management Ltd lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.6% during the 4th quarter, Holdings Channel reports. The firm owned 20,907 shares of the company’s stock after selling 349 shares during the period. HCA Healthcare makes up about 1.3% of Te Ahumairangi Investment Management Ltd’s holdings, making the stock its 24th biggest position. Te Ahumairangi Investment Management Ltd’s holdings in HCA Healthcare were worth $6,275,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. First Eagle Investment Management LLC increased its position in shares of HCA Healthcare by 0.5% during the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after acquiring an additional 23,177 shares during the period. Geode Capital Management LLC raised its position in HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock valued at $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Norges Bank acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $840,286,000. Franklin Resources Inc. raised its holdings in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after acquiring an additional 174,946 shares in the last quarter. Finally, Royal London Asset Management Ltd. increased its position in shares of HCA Healthcare by 62.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after purchasing an additional 574,239 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of analyst reports. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial cut their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Performance

NYSE:HCA opened at $345.86 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a market cap of $85.15 billion, a price-to-earnings ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm’s fifty day moving average price is $325.79 and its 200 day moving average price is $340.25.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company earned $5.90 earnings per share. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare’s dividend payout ratio is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.